MXPA03006473A - Uso de 3-o-a-l-ramnopiranosil (1-2)[b-d-glucopiranosil (1-4)]-a-l-arabinopiranosido de hederagenina o un extracto de pulsatillae radix que contiene lo mismo como un agente terapeutico para tumores solidos. - Google Patents

Uso de 3-o-a-l-ramnopiranosil (1-2)[b-d-glucopiranosil (1-4)]-a-l-arabinopiranosido de hederagenina o un extracto de pulsatillae radix que contiene lo mismo como un agente terapeutico para tumores solidos.

Info

Publication number
MXPA03006473A
MXPA03006473A MXPA03006473A MXPA03006473A MXPA03006473A MX PA03006473 A MXPA03006473 A MX PA03006473A MX PA03006473 A MXPA03006473 A MX PA03006473A MX PA03006473 A MXPA03006473 A MX PA03006473A MX PA03006473 A MXPA03006473 A MX PA03006473A
Authority
MX
Mexico
Prior art keywords
alpha
arabinopyranoside
hederagenin
rhamnopyranosyl
glucopyranosyl
Prior art date
Application number
MXPA03006473A
Other languages
English (en)
Inventor
Kim Song-Bae
Original Assignee
Kim Song-Bae
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Song-Bae filed Critical Kim Song-Bae
Publication of MXPA03006473A publication Critical patent/MXPA03006473A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA03006473A 2002-07-22 2003-07-18 Uso de 3-o-a-l-ramnopiranosil (1-2)[b-d-glucopiranosil (1-4)]-a-l-arabinopiranosido de hederagenina o un extracto de pulsatillae radix que contiene lo mismo como un agente terapeutico para tumores solidos. MXPA03006473A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020043016A KR100568607B1 (ko) 2002-07-22 2002-07-22 헤데라게닌3-O-α-L-람노피라노실(1→2)-[β-D-글루코피라노실(1→4)]-α-L-아라비노피라노사이드 또는 그를 함유하는백두옹 추출물의 고형암 치료제로서의 용도

Publications (1)

Publication Number Publication Date
MXPA03006473A true MXPA03006473A (es) 2004-02-04

Family

ID=30439383

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006473A MXPA03006473A (es) 2002-07-22 2003-07-18 Uso de 3-o-a-l-ramnopiranosil (1-2)[b-d-glucopiranosil (1-4)]-a-l-arabinopiranosido de hederagenina o un extracto de pulsatillae radix que contiene lo mismo como un agente terapeutico para tumores solidos.

Country Status (15)

Country Link
US (3) US20040082528A1 (es)
EP (1) EP1388542B1 (es)
JP (1) JP4642330B2 (es)
KR (1) KR100568607B1 (es)
CN (1) CN1308000C (es)
AT (1) ATE373670T1 (es)
AU (1) AU2003208120B2 (es)
BR (1) BR0302590A (es)
CA (1) CA2435524C (es)
DE (1) DE60316389T2 (es)
DK (1) DK1388542T3 (es)
ES (1) ES2292883T3 (es)
MX (1) MXPA03006473A (es)
RU (1) RU2325178C2 (es)
TW (1) TWI280881B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP702498A0 (en) * 1998-11-09 1998-12-03 Silverbrook Research Pty Ltd Image creation method and apparatus (ART77)
US20050163734A1 (en) * 2002-09-23 2005-07-28 Kim Jong S. Cosmetic composition having whitening effect comprising extract of pulsatilla radix as main ingredient
KR100667955B1 (ko) * 2004-05-07 2007-01-15 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
KR100628334B1 (ko) * 2004-07-30 2006-09-27 김송배 백두옹의 항암효과를 증진시키는 방법 및 이 방법으로제조된 항암 조성물
JP4892833B2 (ja) * 2004-12-17 2012-03-07 大正製薬株式会社 脂肪吸収抑制剤
WO2006083050A1 (en) 2005-02-03 2006-08-10 Sk Chemicals, Co., Ltd. Pulsatilla spp. extracts effective in brain function
KR100748248B1 (ko) * 2006-06-26 2007-08-10 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
CN102199184B (zh) * 2011-04-07 2013-03-06 江西本草天工科技有限责任公司 一种常春藤皂苷类衍生物、其盐的制备方法及其抗肿瘤的用途
CN102178688B (zh) * 2011-04-07 2012-11-21 江西本草天工科技有限责任公司 一种常春藤皂苷类成分的制备方法及其抗肿瘤的用途
CN102633857A (zh) * 2012-04-24 2012-08-15 吉林大学 一种常春藤皂苷元的提取方法
JP2012246311A (ja) * 2012-09-05 2012-12-13 Sk Chemicals Co Ltd 脳機能改善効果を有するオキナグサ抽出物
CN104622880B (zh) * 2015-02-09 2017-05-17 南京医科大学第一附属医院 一种抗肿瘤药物组合物
CN104761610A (zh) * 2015-02-10 2015-07-08 江西本草天工科技有限责任公司 一类新型的α-常春藤皂苷衍生物及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670523A (es) * 1964-10-09
KR940000234B1 (ko) * 1989-09-04 1994-01-12 김송배 신규 항암작용을 가지는 약학적 제제 및 제조방법
US5098870A (en) * 1990-07-12 1992-03-24 Lanxide Technology Company, Lp Process for preparing self-supporting bodies having controlled porosity and graded properties and products produced thereby
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
KR0128494B1 (ko) * 1994-07-26 1998-04-04 최무섭 색전이 없는 생약 추출물-함유 줄무늬 치약 조성물
KR100205045B1 (ko) * 1996-12-05 1999-06-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
ATE340191T1 (de) * 1997-07-02 2006-10-15 Univ Washington Methoden zur isolation von proteinaseinhibitor proteinen von kartoffeln knollen
KR19990016761A (ko) * 1997-08-19 1999-03-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
KR100315200B1 (ko) 1998-11-10 2002-03-21 김송배 데옥시포도필로톡신을유효성분으로함유하는고형암치료제조성물
KR100340941B1 (ko) * 1999-05-14 2002-06-20 김일웅 항 종양 효과가 있는 화합물 및 그것을 함유하는 항종양제
US6686456B2 (en) * 2001-07-06 2004-02-03 Kemin Foods, L.C. Method for the elimination of Kunitz and Bowman-Birk trypsin inhibitors and carboxypeptidase inhibitor from potato proteins
US7371418B2 (en) * 2001-07-06 2008-05-13 Sheabar Fayad Z Method for controlling the yield and purity of proteinase inhibitor II during extraction

Also Published As

Publication number Publication date
KR20040009172A (ko) 2004-01-31
RU2003122817A (ru) 2005-01-27
CA2435524A1 (en) 2004-01-22
DE60316389D1 (de) 2007-10-31
US20050239718A1 (en) 2005-10-27
ATE373670T1 (de) 2007-10-15
TW200410704A (en) 2004-07-01
JP4642330B2 (ja) 2011-03-02
KR100568607B1 (ko) 2006-04-07
CN1494910A (zh) 2004-05-12
CN1308000C (zh) 2007-04-04
US20100152124A1 (en) 2010-06-17
AU2003208120B2 (en) 2008-09-11
US20040082528A1 (en) 2004-04-29
RU2325178C2 (ru) 2008-05-27
EP1388542B1 (en) 2007-09-19
AU2003208120A1 (en) 2004-02-05
ES2292883T3 (es) 2008-03-16
DK1388542T3 (da) 2008-01-02
JP2004051641A (ja) 2004-02-19
US7682638B2 (en) 2010-03-23
TWI280881B (en) 2007-05-11
DE60316389T2 (de) 2008-06-26
CA2435524C (en) 2009-11-03
BR0302590A (pt) 2004-08-24
EP1388542A1 (en) 2004-02-11
US8075923B2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
MXPA03006473A (es) Uso de 3-o-a-l-ramnopiranosil (1-2)[b-d-glucopiranosil (1-4)]-a-l-arabinopiranosido de hederagenina o un extracto de pulsatillae radix que contiene lo mismo como un agente terapeutico para tumores solidos.
MY138074A (en) Somatostatin analogues
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
DK1914237T3 (da) Antivirale fosfonatesterforbindelser
TR199901077A2 (en) �spen�iyari form�lasyonlar.
TW200407305A (en) Novel compounds
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
MXPA04000210A (es) Conjugados quelantes mejorados.
DE60214359D1 (en) Stickstoffbasierte camptothecin-derivate
MXPA04003755A (es) Endoprotesis vasculares.
SE9904044D0 (sv) Compounds
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
SE9904045D0 (sv) Compounds
GB2348423B (en) Novel anhydrofructose antioxidant
NO20034529D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer samt antiarytmiforbindelser
FR2842109B1 (fr) Utilisation d'un extrait de chrysanthellum
PL366434A1 (en) Oral composition comprising an extract from the bark of albizzia myriophylla
AU2000263936A1 (en) Substance p analogs for the treatment of cancer
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
TW200603801A (en) Novel dialkoxy-imidazopyridines
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
BR0214244A (pt) Uso de uma ascomicina

Legal Events

Date Code Title Description
FG Grant or registration